Premium
Cyclodialysis cleft repair: A multi‐centred, retrospective case series
Author(s) -
Popovic Marko,
Shareef Shakeel,
Mura Juan J.,
Valenzuela Felipe,
González MartínMoro Julio,
Schlenker Matthew B.,
Barton Keith,
MuñozNegrete Francisco,
Razeghinejad Mohammad Reza,
Ahmed Iqbal Ike K.
Publication year - 2019
Publication title -
clinical and experimental ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.3
H-Index - 74
eISSN - 1442-9071
pISSN - 1442-6404
DOI - 10.1111/ceo.13378
Subject(s) - medicine , intraocular pressure , retrospective cohort study , visual acuity , surgery , ophthalmology
Importance There is a paucity of evidence analysing the treatment of cyclodialysis clefts. Background We describe outcomes following the treatment of this rare condition at six centres internationally. Design Retrospective case series. Participants Thirty‐six patients with a cyclodialysis cleft from 2003 to 2017 were recruited. Methods Clefts were treated with cycloplegic agents, laser therapy and/or surgery. Main Outcome Measures Postoperative best recorded visual acuity (BRVA), intraocular pressure (IOP) and the rate of cleft closure. Results The mean age was 45 ± 17 years and 29 (80.6%) patients were male. One eye (2.8%) received only medical therapy, 5 (13.9%) received laser, 14 (38.9%) underwent surgery after laser failure and 16 (44.4%) eyes received exclusively surgery. Over 80% of eyes had a BRVA improvement of more than two lines. Closure was attained in 30 eyes (93.8%; n = 32), with postoperative stabilized IOP ≥ 12 mmHg in 29 eyes (80.6%; n = 36) and postoperative BRVA ≤20/50 in 20 eyes (58.8%; n = 34). Improved postoperative BRVA was related to better preoperative BRVA ( P = 0.006) and preoperative IOP ≥ 4 mmHg ( P = 0.03). There was no significant difference between treatment approach for IOP ≥ 12 mmHg ( P = 0.85) or postoperative BRVA ≤20/50 ( P = 0.80). Only two eyes at last follow‐up required IOP lowering medication. Conclusions and Relevance There was a high closure rate with most eyes eventually requiring surgery. Clinically significant improvements in BRVA were found in most eyes. Improved postoperative BRVA was significantly related to better preoperative BRVA and IOP.